Teeft.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Teeft.i » - entrée « Assay »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Aspirin users < Assay < Assay measures  Facettes :

List of bibliographic references indexed by Assay

Number of relevant bibliographic references: 79.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
002905 (2013) The 24th Annual Meeting of Japanese Society of Neuroimmunology (JSNI)
002B47 (2013) Y. Saeki ; S. Ohshima ; M. Matsushita ; E. Tanaka-Kudo ; S. Tsuji ; M. Yoshimura ; A. Watanabe ; M. Katayama ; S. Teshigawara ; Y. Katada ; Y. Harada ; A. Yura ; K. Kagawa ; J. Hashimoto ; S. Tohma [Japon]SAT0144 The Causes of Discontinuation of Biologics(Bio)-Use in the Treatment of Rheumatoid Arthritis (RA) Under Practical Circumstances in Japan: from the “Ninja” Registry
002B48 (2013) Y. Yabe [Japon] ; T. Kojima ; A. Kaneko ; Y. Kanayama ; Y. Hirano ; T. Shioura ; K. Saito [Japon] ; N. Asai ; T. Kobayakawa ; N. IshiguroSAT0143 Analysis of Patients Who Obtained Remission by Disease Activity Score After Tocilizumab Treatment But Still had Low Disease Activity by Clinical Disease Activity Index, and Examination of Points for Treatment Intensification
002B49 (2013) U. Klein [Suisse] ; E. Liang [Suisse] ; B. Vogel [Suisse] ; F. Kolbinger [Suisse] ; G. Bruin [Suisse] ; P. Lloyd [Suisse]SAT0142 Immunogenicity of the Novel Anti-Il-17A Antibody, Secukinumab, with Intravenous and Subcutaneous Dosing Regimens in Healthy Subjects and Patients
002B50 (2013) T. Kasama [Japon] ; M. Umemura [Japon] ; S. Isojima [Japon] ; T. Tokunaga [Japon] ; H. Tsukamoto [Japon] ; R. Yanai [Japon] ; H. Furuya [Japon] ; Y. Miwa [Japon]SAT0141 Correlation of Serum Macrophage Migration Inhibitory Factor Levels With Response to Tocilizumab Therapy in Patients with Rheumatoid Arthritis
002C26 (2013) Herbert Struemper [États-Unis] ; Cecil Chen [États-Unis] ; Wendy Cai [États-Unis]Population Pharmacokinetics of Belimumab Following Intravenous Administration in Patients With Systemic Lupus Erythematosus
002C36 (2013) OS42: Interstitial Lung Disease 6
002C37 (2013) OS41: Tuberculosis 5
002C38 (2013) OS40: COPD 4
002C39 (2013) OS39: Clinical Allergy & Immunology
002C40 (2013) OS38: Interstitial Lung Disease 5
002C41 (2013) OS37: Tuberculosis 4
002C42 (2013) OS36: COPD 3
002C43 (2013) OS35: Environmental & Occupational Health and Epidemiology
002C44 (2013) OS34: Others 2
002C45 (2013) OS33: Tuberculosis 3
002C46 (2013) OS32: Respiratory Neurobiology and Sleep
002C47 (2013) OS31: Paediatric Lung Disease
002C48 (2013) OS30: Interstitial Lung Disease 4
002C49 (2013) OS29: Bronchoscopy and Interventional Techniques 2
002C50 (2013) OS28: Lung Cancer 6

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Assay" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Assay" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Assay
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021